You are here

  • Home
  • Archive
  • Volume 2017, Issue
  • Endogenous endophthalmitis and osteomyelitis associated with interleukin 17 inhibitor treatment for psoriasis in a patient with diabetes

Article metrics

Article menu
Download PDFPDF
Unexpected outcome (positive or negative) including adverse drug reactions
CASE REPORT
Endogenous endophthalmitis and osteomyelitis associated with interleukin 17 inhibitor treatment for psoriasis in a patient with diabetes

 

Online download statistics by month:

Online download statistics by month: June 2017 to March 2024

AbstractFullPdf
Jun 20176700
Jul 20172442235
Aug 20173394
Sep 20171433
Oct 20173646
Nov 20171534
Dec 20171322
Jan 20187511
Feb 201811433
Mar 20189102
Apr 20182333
May 20186558
Jun 20182130
Jul 20184765
Aug 201826614
Sep 20181800
Oct 20182713
Nov 20182230
Dec 20184654
Jan 20197474
Feb 201912235
Mar 201913971
Apr 20195036
May 20194067
Jun 20195343
Jul 20191932
Aug 20193421
Sep 20193313
Oct 20193831
Nov 20191532
Dec 20193721
Jan 20203222
Feb 20202120
Mar 20201001
Apr 20202201
May 20201610
Jun 20203021
Jul 20204110
Aug 20204311
Sep 20202400
Oct 20206851
Nov 20204232
Dec 20204411
Jan 20212311
Feb 20214900
Mar 20212600
Apr 20211620
May 2021400
Jun 2021321
Aug 2021002
Sep 2021110
Oct 20213821
Nov 20211732
Dec 20212810
Jan 20223300
Feb 20221460
Mar 20224302
Apr 202239123
May 20223820
Jun 20223601
Jul 20226111
Aug 20221800
Sep 20223201
Oct 20221620
Nov 2022800
Dec 20221401
Jan 20231020
Feb 20231110
Mar 20237212
Apr 20233460
May 20232801
Jun 20231410
Jul 20231710
Aug 20233130
Sep 20231811
Oct 20231600
Nov 20233421
Dec 20232600
Jan 20242110
Feb 20246200
Mar 20246411
Total3059196165